Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

242 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Targeting Inhibitor of κB Kinase β Prevents Inflammation-Induced Preterm Delivery by Inhibiting IL-6 Production from Amniotic Cells.
Toda A, Sawada K, Fujikawa T, Wakabayashi A, Nakamura K, Sawada I, Yoshimura A, Nakatsuka E, Kinose Y, Hashimoto K, Mabuchi S, Tokuhira A, Nakayama M, Itai A, Kurachi H, Kimura T. Toda A, et al. Among authors: kurachi h. Am J Pathol. 2016 Mar;186(3):616-29. doi: 10.1016/j.ajpath.2015.11.004. Epub 2016 Jan 12. Am J Pathol. 2016. PMID: 26796146 Free article.
miR-92a inhibits peritoneal dissemination of ovarian cancer cells by inhibiting integrin α5 expression.
Ohyagi-Hara C, Sawada K, Kamiura S, Tomita Y, Isobe A, Hashimoto K, Kinose Y, Mabuchi S, Hisamatsu T, Takahashi T, Kumasawa K, Nagata S, Morishige K, Lengyel E, Kurachi H, Kimura T. Ohyagi-Hara C, et al. Among authors: kurachi h. Am J Pathol. 2013 May;182(5):1876-89. doi: 10.1016/j.ajpath.2013.01.039. Epub 2013 Mar 15. Am J Pathol. 2013. PMID: 23499550
IKKβ Regulates VEGF Expression and Is a Potential Therapeutic Target for Ovarian Cancer as an Antiangiogenic Treatment.
Kinose Y, Sawada K, Makino H, Ogura T, Mizuno T, Suzuki N, Fujikawa T, Morii E, Nakamura K, Sawada I, Toda A, Hashimoto K, Isobe A, Mabuchi S, Ohta T, Itai A, Morishige K, Kurachi H, Kimura T. Kinose Y, et al. Among authors: kurachi h. Mol Cancer Ther. 2015 Apr;14(4):909-19. doi: 10.1158/1535-7163.MCT-14-0696. Epub 2015 Jan 30. Mol Cancer Ther. 2015. PMID: 25637316
Interleukin 6 receptor is an independent prognostic factor and a potential therapeutic target of ovarian cancer.
Isobe A, Sawada K, Kinose Y, Ohyagi-Hara C, Nakatsuka E, Makino H, Ogura T, Mizuno T, Suzuki N, Morii E, Nakamura K, Sawada I, Toda A, Hashimoto K, Mabuchi S, Ohta T, Morishige K, Kurachi H, Kimura T. Isobe A, et al. Among authors: kurachi h. PLoS One. 2015 Feb 6;10(2):e0118080. doi: 10.1371/journal.pone.0118080. eCollection 2015. PLoS One. 2015. PMID: 25658637 Free PMC article.
Potential role of mTORC2 as a therapeutic target in clear cell carcinoma of the ovary.
Hisamatsu T, Mabuchi S, Matsumoto Y, Kawano M, Sasano T, Takahashi R, Sawada K, Ito K, Kurachi H, Schilder RJ, Testa JR, Kimura T. Hisamatsu T, et al. Among authors: kurachi h. Mol Cancer Ther. 2013 Jul;12(7):1367-77. doi: 10.1158/1535-7163.MCT-12-1185. Epub 2013 Apr 24. Mol Cancer Ther. 2013. PMID: 23615631 Free PMC article.
Uterine cervical cancer displaying tumor-related leukocytosis: a distinct clinical entity with radioresistant feature.
Mabuchi S, Matsumoto Y, Kawano M, Minami K, Seo Y, Sasano T, Takahashi R, Kuroda H, Hisamatsu T, Kakigano A, Hayashi M, Sawada K, Hamasaki T, Morii E, Kurachi H, Matsuura N, Kimura T. Mabuchi S, et al. Among authors: kurachi h. J Natl Cancer Inst. 2014 Jun 19;106(7):dju147. doi: 10.1093/jnci/dju147. Print 2014 Jul. J Natl Cancer Inst. 2014. PMID: 24948742
242 results